Mitral valve replacement

Tendyne™ TMVR System is first-in-class technology designed to eliminate mitral regurgitation (MR), offering select patients with MR (≥ grade 3), a novel option for mitral valve replacement. Tendyne TMVR provides symptom relief by eliminating MR.

– Beating heart procedure without the need for cardiopulmonary bypass or rapid pacing;
– Complete MR elimination in 99% of patients at 30 days;
– Sustained MR elimination in 93% of patients at 2 years;
– 96% technical success rate;
– System is fully repositionable and retrievable at any point intraprocedurally;
– Significant improvement in symptom and quality-of-life measures;
– Low mean mitral gradient of 3.2 mm Hg at 2 years;